A detailed history of Hemington Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Hemington Wealth Management holds 858 shares of LLY stock, worth $676,267. This represents 0.19% of its overall portfolio holdings.

Number of Shares
858
Previous 891 3.7%
Holding current value
$676,267
Previous $806,000 11.79%
% of portfolio
0.19%
Previous 0.27%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $25,480 - $31,680
-33 Reduced 3.7%
858 $711,000
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $33,344 - $41,815
46 Added 5.44%
891 $806,000
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $25,464 - $34,068
43 Added 5.36%
845 $658,000
Q4 2023

Jan 26, 2024

SELL
$525.19 - $619.13 $16,806 - $19,812
-32 Reduced 3.84%
802 $468,000
Q3 2023

Oct 20, 2023

SELL
$434.7 - $599.3 $73,029 - $100,682
-168 Reduced 16.77%
834 $447,000
Q2 2023

Aug 04, 2023

SELL
$350.74 - $468.98 $15,783 - $21,104
-45 Reduced 4.3%
1,002 $469,000
Q1 2023

May 05, 2023

BUY
$310.63 - $364.82 $5,901 - $6,931
19 Added 1.85%
1,047 $359,000
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $5,466 - $6,369
17 Added 1.68%
1,028 $376,000
Q3 2022

Oct 31, 2022

BUY
$296.48 - $337.87 $4,150 - $4,730
14 Added 1.4%
1,011 $327,000
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $4,738 - $5,563
17 Added 1.73%
997 $323,000
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $229,996 - $285,826
980 New
980 $281,000
Q4 2021

Jan 13, 2022

SELL
$224.85 - $279.04 $222,376 - $275,970
-989 Closed
0 $0
Q3 2021

Oct 06, 2021

BUY
$221.6 - $272.71 $3,324 - $4,090
15 Added 1.54%
989 $229,000
Q2 2021

Jul 09, 2021

BUY
$180.55 - $233.54 $175,855 - $227,467
974 New
974 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.